Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Big Pharma to seek only selected generics opportunities, IMS predicts

This article was originally published in Scrip

Executive Summary

IMS Health made two significant predictions, among others, at the 13th annual International Generic Pharmaceutical Alliance (IGPA) conference in Mumbai. One was that Big Pharma is unlikely to emerge as a 'long-list' generics player, which appeared to be something that many in the audience anticipated and accepted.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC011126

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel